Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Carolina Angel Network
AddedFeb 15, 2024
UpdatedJun 28, 2026
Carolina Angel Network

Carolina Angel Network

Operating

CAN: A US-based venture capital firm investing in healthcare, energy drinks, and subscription services.

Location
Chapel Hill, NC, US
Founded
2016
Firm
Compare
Portfolio
Employees
Website

Carolina Angel Network (CAN) is a venture capital firm based in the United States, focusing on investments in healthcare, medical devices, energy drink manufacturing, and air filter delivery subscription services. CAN typically participates in Seed and Series A funding rounds, with occasional involvement in Series C and other unspecified rounds.

Notable portfolio companies include Pryon, which has raised $24,050,000, Gemelli Biotech with $19,000,000 raised, and Second Nature with $16,400,000. The firm’s investment philosophy centers on supporting innovative startups within their targeted sectors. CAN offers unique value-add services to its portfolio companies, leveraging deep industry expertise and a robust network to facilitate growth and success.

Carolina Angel Network - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments12
Current Portfolio Count10
Total Portfolio Exits1

Top Investment Stages

Seed5 (41.7%)
Series A5 (41.7%)
Series C1 (8.3%)
Series Unknown1 (8.3%)

Stage Mix

Seed 42%Series A 42%Series C 8%Series Unknown 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Pryon logo

Pryon

Gemelli Biotech logo

Gemelli Biotech

Swir Vision Systems logo

Swir Vision Systems

Revibe Technologies logo

Revibe Technologies

EternaTear logo

EternaTear

The Looma Project logo

The Looma Project

Second Nature logo

Second Nature

Roobrik logo

Roobrik

Emergo Therapeutics logo

Emergo Therapeutics

Carpe logo

Carpe

Alievio logo

Alievio

Carolina Angel Network - Similar Investment Firms

Upstate Carolina Angel Network logo

Upstate Carolina Angel Network

Triangle Angel Partners logo

Triangle Angel Partners

Charlottesville Angel Network logo

Charlottesville Angel Network

Columbia Angel Network logo

Columbia Angel Network

Piedmont Angel Network logo

Piedmont Angel Network

Charlotte Angel Partners logo

Charlotte Angel Partners

cltangelfund.com

Canrock Ventures logo

Canrock Ventures

Nashville Capital Network logo

Nashville Capital Network

North Country Angels logo

North Country Angels

Country Roads Angel Network logo

Country Roads Angel Network

wvcran.com

CannaAngels logo

CannaAngels

cannaangelsllc.com

Georgian Angel Network logo

Georgian Angel Network

SideCar Angels logo

SideCar Angels

sidecarangels.com

Granite State Angels logo

Granite State Angels

ARC Angel Fund logo

ARC Angel Fund

arcangelfund.com

Carolina Angel Network - Classification

Also Known As
  • Carolina Angel Network LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end